Dronedarone Hydrochloride

盐酸决奈达隆

Report date: 2022/08/16 15:41:43
NME

Base Information

Drug NameDronedarone Hydrochloride
Drug Alias Namedronedarona决奈达隆盐酸盐Drondarone屈奈达隆dronedaronum +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersPotassium channel blockersVoltage-gated calcium channel blockers +[6] 
TargetsPotassium channelSodium channel alpha subunitVoltage-gated calcium channel +[6] 
Therapy Area/IndicationsHeart FailureTachycardiaAtrial Flutter +[5] 
Global Approved IndicationsTachycardiaAtrial FlutterAtrial Fibrillation
Approved Indications in ChinaTachycardiaAtrial FlutterAtrial Fibrillation
Original Approved Country/TerritoryUnited States
Original Approved Date2009/07/01
Country/TerritoryCzechiaBelgiumBulgaria +[48] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofiSanofi-Aventis U.S. LlcSanofi Winthrop Industrie SA
Inactive CompaniesUtah State University
Active IndicationsTachycardiaAtrial FlutterAtrial Fibrillation +[4] 
Inactive IndicationsHeart Failure

Other Information

ATC CodeC01BD07
Related LinksWikipediaDrugBankKEGG